123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo

G. Bakker, W.A. Vingerhoets, J.P. van Wieringen, K. de Bruin, J.L.H. Eersels, J. de Jong, Y. Chahid, B.P. Rutten, S. DuBois, M. Watson, A.J. Mogg, H. Xiao, M. Crabtree, D. A. Collier, C.C. Felder, V.N. Barth, L.M. Broad, O.J. Bloemen, T.A. van Amelsvoort, J. Booij

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)317-322
JournalJournal of Nuclear Medicine
Volume56
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

Bakker, G., Vingerhoets, W. A., van Wieringen, J. P., de Bruin, K., Eersels, J. L. H., de Jong, J., ... Booij, J. (2015). 123I-iododexetimide preferentially binds to the muscarinic receptor subtype M1 in vivo. Journal of Nuclear Medicine, 56(2), 317-322. https://doi.org/10.2967/jnumed.114.147488